Stryker Corp is a strong company operationally, have a great history, rumored to be looking to acquire ‘Boston Scientific’ and they are the largest drop in the S/P500 today.
I’m pretty dumb, other than the cost to acquire, and then new operating costs, what are significant risks of a biotech/supply company to swallow up another company that would cause this seemingly temporary dip?
I have a small position, and may stay up to listen to the last few ER and do some light reading about them.
Any thoughts?
Submitted June 11, 2018 at 11:00PM by PizzaPlanetCool https://ift.tt/2JCXzz1
